Daily Bulletin


  • Written by Paul Komesaroff, Professor of Medicine, Monash University
The coronavirus pandemic is forcing us to ask some very hard questions. But are we ready for the answers?

The global coronavirus pandemic poses immediate, wide-ranging ethical challenges for governments, health authorities, health workers and the public.

At the heart of these challenges is how best to respond to COVID-19 urgently, yet safely and fairly.

How do we ensure rapid development and delivery of vaccines and other medicines, ethically and with proper oversight? How do we ration and distribute limited healthcare resources? How many of our personal freedoms are we willing to forgo to contain the pandemic?

How do we do this while protecting the vulnerable?

Read more: Why public health officials sound more worried about the coronavirus than the seasonal flu

This situation is unique

We ask these hard questions in a unique and rapidly changing environment, with the number of cases and deaths due to COVID-19 rising daily, and with increased global mobility leading to unstoppable transmission across borders.

The urgency of the situation is even forcing us to rethink how we answer these questions.

Traditionally, we make ethical decisions after open dialogue to achieve mutual understanding.

Such dialogue is placed under stress in times of crisis where, because decisions have to be made rapidly, authorities seek to suspend or dispense with time-honoured checks and balances.

However, it is precisely in these potentially dangerous situations that we most need nuanced ethical conversations.

Here are three key examples of the ethical challenges we face.

1. How do we develop new drugs quickly yet safely?

The first is how to balance the unknown risks associated with developing a vaccine or other drugs with the need for a response rapid enough to limit spread of the virus.

Part of that challenge is to ensure there is enough oversight of clinical trials when we are also accelerating the delivery of new therapies.

We will have to decide whether it is appropriate to accept higher levels of risk to research participants and patients when the stakes are higher.

Read more: Infecting healthy people in vaccine research can be ethical and necessary

As well as the risks there are also potential benefits.

It has taken many years to construct an elaborate framework to ensure clinical research is conducted ethically.

However, under the pressure of the current emergency we may be able to find ways to reduce bureaucracy and red tape, speed up decision-making and make the system more responsive.

These changes may serve us well in the future, when we return to “business as usual”.

Read more: Here's why the WHO says a coronavirus vaccine is 18 months away

2. How prepared are we to give up some personal freedoms?

Balancing our personal freedoms – such as freedom of movement and the right to choose or decline medical treatment – with limiting the spread of disease is another major challenge.

We have seen disturbing images from Wuhan in China of officials apparently detaining citizens walking along the street, or dragging them from their homes.

How prepared are we to give up our personal freedoms, such as the right to choose or decline medical treatment?

Australia has announced plans for legislation allowing people to be detained or isolated when they are said to pose a threat to public safety.

Read more: Explainer: what are the Australian government's powers to quarantine people in a coronavirus outbreak?

At the same time, community organisations are mobilising to protect and support vulnerable members of society by providing food or other services. Health practitioners will continue to serve their patients with courage and dedication, even when this places them in danger.

How can we ensure such ethical values prevail over increasing authoritarian power?

How much of our personal freedom will we be prepared to give up in support of public health demands? Will we accept self-quarantine at home or isolation in a medical facility? Will we allow authorities to enter people’s homes and arrest infected people?

There is a great risk the emergency measures introduced will continue and be absorbed into everyday practice when the crisis ends. Will we be able to prevent this?

3. How do we allocate scarce resources?

Finally, there is the question of how best to allocate scarce resources, such as drugs, access to intensive care treatments, personal protective equipment, staff and research funding.

As the number of cases increases globally the number of critically ill patients will quickly exceed the available facilities, requiring us to make difficult choices.

Read more: Coronavirus: should frontline doctors and nurses get preferential treatment?

We will have to decide who is treated where, who has access to scarce drugs or technologies, how and for whose benefit health professionals and emergency services are deployed, and how food, protective clothing and other items are rationed.

Medical professionals have long been familiar with such discussions, which are now likely to become more routine.

Read more: How do we choose who gets the flu vaccine in a pandemic – paramedics, prisoners or the public?

What lies ahead?

We will need to make these decisions in a democratic way with public involvement, rather than leaving them to experts or government authorities.

We will need to struggle to preserve the ethical values of mutual respect and responsibility, fairness, and care for vulnerable members of society, which may be difficult in our present harsh and uncompromising times.

There are no easy solutions to satisfy everyone. However, at least we can start talking about these issues. For now, maybe that’s the best we can do.

Authors: Paul Komesaroff, Professor of Medicine, Monash University

Read more https://theconversation.com/the-coronavirus-pandemic-is-forcing-us-to-ask-some-very-hard-questions-but-are-we-ready-for-the-answers-132581

Writers Wanted

Confused about which English subject to choose in year 11 and 12? Here's what you need to know


We've heard of R numbers and moving averages. But what are k numbers? And how do they explain COVID superspreading?


The Conversation


Prime Minister Scott Morrison's interview with Ray Hadley, 2GB

RAY HADLEY: Prime Minister, good morning to you.   PRIME MINISTER: G’day, Ray.   HADLEY: Gee, you’ve had a week.   PRIME MINISTER: Well, there's been a lot of weeks like this. This time last...

Scott Morrison - avatar Scott Morrison

Ray Hadley's interview with Scott Morrison

RAY HADLEY: I'm going to go straight to the Prime Minister, Scott Morrison is on the line right now. Prime Minister, good morning to you.    PRIME MINISTER: Good morning, Ray.   HADLEY: Just d...

Ray Hadley - avatar Ray Hadley

Defence and Veterans suicide Royal Commission

Today the Government has formally established a Royal Commission into Defence and Veteran Suicide following approval by the Governor-General.   Prime Minister Scott Morrison said the Royal Commi...

Scott Morrison - avatar Scott Morrison

Business News

9 Smart Hacks for Your First Day at Work

No matter how much work experience you have, the first day with a new company can be very stressful. Even the biggest professionals find the change of location and work collective a little frighte...

Chloe Taylor - avatar Chloe Taylor

Record year of growth for Tweed based business The Electrical Co

While many businesses struggled to stay afloat during the COVID-19 affected 2021 financial year, Tweed Heads based The Electrical Co. completed more than 50,000 smart meter installations across Aust...

a contributor - avatar a contributor

The Most Common Reasons why Employees End Up Leaving a Company

It is important for businesses to make sure they find the right people for their open positions. That is why a lot of companies are relying on professional outplacement services. A lot of companie...

NewsServices.com - avatar NewsServices.com